help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on August 21, 2007
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-0956
A more recent version of this article appeared on November 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
92/11/4489    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schreiner, F.
Right arrow Articles by Woelfle, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schreiner, F.
Right arrow Articles by Woelfle, J.
Related Collections
Right arrow Neuroendocrinology and Pituitary
Right arrow Pediatric Endocrinology

Submitted on April 27, 2007
Accepted on August 13, 2007

Association of the Growth Hormone Receptor d3-Variant and Catch-up Growth of Preterm Infants with Birth Weight less than 1500 grams

Felix Schreiner, Sonja Stutte, Peter Bartmann, Bettina Gohlke, and Joachim Woelfle*

Pediatric Endocrinology Division and Department of Neonatology, Children's Hospital, University of Bonn, Germany

* To whom correspondence should be addressed. E-mail: joachim.woelfle{at}ukb.uni-bonn.de.

Background: Preterm infants with very low birth weight frequently exhibit impaired longitudinal growth during the first years of life. Recently, the d3-isoform (genomic deletion of exon 3) of the growth hormone receptor (GHR) has been linked to an increased responsiveness to growth hormone (GH).

Objective: To test whether the GHRd3 isoform is associated with postnatal catch-up growth in very low birth weight preterm infants.

Design and Patients: We compared the postnatal growth pattern of 77 otherwise healthy preterm infants (mean gestational age 28.5 weeks, range 23–35 weeks) with a birth weight below 1500 g (mean birth weight 941 g) to their GHR exon 3 genotype, which was analyzed by multiplex PCR. On examination, mean age of the children was 6.0 years (range 4.2–8.0 years).

Results: Children homozygous or heterozygous for the GHRd3-allele showed a significant higher rate of postnatal catch-up, compared to those homozygous for the full-length allele.

Conclusions: Our results define the GHR exon 3 genotype as a predictor for the postnatal growth pattern of very low birth weight preterm infants. Those who carry at least one GHRd3 allele are more likely to catch-up.


Key words: GH receptor • catch-up growth • preterm infants • very low birth weight




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
L. Audi, A. Carrascosa, C. Esteban, M. Fernandez-Cancio, P. Andaluz, D. Yeste, R. Espadero, M. L. Granada, H. Wollmann, L. Fryklund, et al.
The exon 3-deleted/full-length Growth Hormone Receptor Polymorphism Does Not Influence the Effect of Puberty or Growth Hormone Therapy on Glucose Homeostasis in Short Non-Growth Hormone-Deficient Small-for-Gestational-Age Children: Results from a Two-Year Controlled Prospective Study
J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2709 - 2715.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society